August 21, 2017 Last Updated 12:31 pm

Andy Page joins digital health company Livongo Health as President and Chief Financial Officer

Most recently, Page served as President of 23andMe, and before that held several executive positions at other major consumer technology companies

Mountain View, Calif. — August 21, 2017 – Livongo Health, the leading consumer digital health company that empowers people with chronic conditions to live happier and healthier lives, announced today that Andy Page has joined the company as its President and Chief Financial Officer. This executive appointment comes at a time when Livongo has proven their approach to managing diabetes by delivering both clinical and financial results and, most importantly, satisfied members. Livongo is expanding its offerings to address multiple chronic conditions for its more than 200 large enterprise customers.

As President and Chief Financial Officer, Page will lead various financial and operational functions and strategic growth initiatives. He will report to Livongo Chief Executive Officer Glen Tullman.

With over 25 years of leadership experience, Andy has worked with some of the most  innovative consumer-facing companies leveraging the power of technology. His experience scaling data science driven technology companies will be a valuable addition to an already exceptionally strong management team,” said Livongo Chief Executive Officer Glen Tullman. “Andy’s operational experience will also be helpful in managing our accelerating growth and balancing that with our expansion into new products and markets.”

Most recently, Page served as President of 23andMe, the most recognized consumer genetics company. Prior to 23andMe, Page has held several executive positions at other major consumer technology companies. He formerly served as President of Gilt Groupe and CFO at both PlayPhone and StubHub. Page also worked at investment banking leader Robertson Stephens. Page holds a BA from Princeton University and an MBA from Harvard Business School.

“Diabetes is one of the fastest-growing chronic conditions in the world today, and it is also the most manageable with the right information and tools, provided at the right time and backed by insights from data science. Livongo has made significant progress in delivering solutions that make a difference for people in a very personal way, and brought vision and change to an area of healthcare that hasn’t seen a lot of innovation, particularly in type 2 diabetes. My goal is to bring our solution to millions of people who we know we can live healthier and happier lives,” said Page.

Livongo’s digital platform for diabetes management has been implemented by over 200 leading Fortune 500 companies, innovative health systems, and the largest health plans and pharmacy benefit managers.

Comments are closed.